๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Neoadjuvant Chemoimmunotherapy

A Study Comparing Neoadjuvant Chemoimmunotherapy and Immuno-consolidationafter Compared With Immunoconsolidation After Radical Chemoradiotherapy for Stage III Potentially Resectable NSCLC NCT06424899Phase 21 site๐Ÿ“ Hangzhou Zeng Jian ยท Tests: Adebrelimab, radical chemoradiotherapy, Platinum based chemotherapy Neoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer NCT06289751Phase 22 sites๐Ÿ“ Wuhan๐Ÿ“ Jinan Tongji Hospital ยท Tests: Cadonilimab, Paclitaxel-albumin, Cisplatin, Extrafascial hysterectomy, Radical hysterectomy NEoadjuvant Chemotherapy and Immunotherapy for a Selected Group of Inoperable Pleural Mesothelioma Patients (NECIM): a Feasibility Study NCT07121374Phase 1, Phase 21 site๐Ÿ“ Edegem University Hospital, Antwerp ยท Tests: Neoadjuvant chemo-immunotherapy, Extended pleurectomy/decortication in case of reaching operability A Phase II Study of Biomarker-Guided De-escalation Using Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Early-Stage Triple Negative Breast Cancer (TNBC) Patients With High Tumor-Infiltrating Lymphocytes (TILs) NCT07743190Phase 22 sites๐Ÿ“ Syracuse๐Ÿ“ Charleston Medical University of South Carolina ยท Tests: Carboplatin, Paclitaxcel, Pembrolizumab Downstaging and RATS After Neo-Chemo-IO: Impact on Surgical Outcomes in NSCLC NCT07528066n/a10 sites๐Ÿ“ Fuzhou๐Ÿ“ Guangzhou๐Ÿ“ Shenzhen Shanghai Chest Hospital ยท Tests: Robotic-assisted surgery (RATS) Induction Chemoimmunotherapy Combined With Chemoradiotherapy in Esophageal Cancer NCT06421376Phase 23 sites๐Ÿ“ Anyang๐Ÿ“ Xinxiang๐Ÿ“ Beijing Cancer Institute and Hospital, Chinese Academy of Medical Sโ€ฆ ยท Tests: Cardonilizumab, Chemoradiotherapy ยฑimmunotherapy, Radical surgery Perioperative Tislelizumab Plus Chemotherapy for Resectable Thoracic Oesophageal Squamous Cell Carcinoma NCT06056336Phase 21 site๐Ÿ“ Shanghai Guo Xufeng ยท Tests: Tislelizumab Neoadjuvant Immunochemotherapy in PD-L1-negative LACC NCT06288360Phase 212 sites๐Ÿ“ Hefei๐Ÿ“ Beijing๐Ÿ“ Chongqing Tongji Hospital ยท Tests: Camrelizumab, Paclitaxel-albumin, Cisplatin, radical surgery Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC NCT06288373Phase 2, Phase 312 sites๐Ÿ“ Hefei๐Ÿ“ Beijing๐Ÿ“ Chongqing Tongji Hospital ยท Tests: Camrelizumab, Cisplatin, Nab paclitaxel, Radical surgery, external beam radiation therapy (EBRT) + brachytherapy Iparomlimab and Tuvonralimab Plus Paclitaxel and Platinum as Neoadjuvant Therapy for Locally Advanced Cervical Cancer NCT07646301Phase 21 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: Iparomlimab and Tuvonralimab (QL1706), Paclitaxel, Cisplatin, Carboplatin Multicenter, Single-Arm, Prospective Phase II Study of Neoadjuvant Cryo-Thermal Ablation Combined With Toripalimab and Chemotherapy for Resectable Stage IB-IIIB Non-Small Cell Lung Cancer NCT07855965Phase 29 sites๐Ÿ“ Chengdu๐Ÿ“ Chengdu๐Ÿ“ Chengdu West China Hospital ยท Tests: Cryo-Thermal Ablation, Toripalimab, Platinum-based doublet chemotherapy Neoadjuvant Chemoimmunotherapy Followed by Surgery and Postoperative Radioimmunotherapy NCT06602843NA1 site๐Ÿ“ Hefei Anhui Provincial Hospital ยท Tests: Neoadjuvant chemoimmunotherapy followed by surgery and postoperative radioimmunotherapy Prospective Observational Study of Baseline Tumor Genomic Profiling and Circulating Tumor DNA in Neoadjuvant Chemoimmunotherapy for Stage IB-III Non-Small Cell Lung Cancer NCT06907160n/a1 site๐Ÿ“ Seoul Yonsei University Tolecizumab Plus Chemoimmunotherapy for pMMR/MSS Locally Advanced Colon Adenocarcinoma NCT07468630Phase 21 site๐Ÿ“ Chongqing Daping Hospital and the Research Institute of Surgery of thโ€ฆ ยท Tests: Tolecizumab (PCSK9 Inhibitor), Sintilimab dCRT vs. Surgery in Resectable ESCC Patients Achieving cCR/PR After Induction Chemoimmunotherapy NCT07162506Phase 21 site๐Ÿ“ Tianjin Tianjin Medical University Cancer Institute and Hospital ยท Tests: Surgery, Radiotherapy, Chemotherapy, Immunotherapy RATS Sleeve Lobectomy After Neo-Chemo-IO for NSCLC NCT07541521n/a10 sites๐Ÿ“ Fuzhou๐Ÿ“ Guangzhou๐Ÿ“ Shenzhen Shanghai Chest Hospital ยท Tests: Robot-assisted thoracoscopic surgery (RATS) sleeve lobectomy Neoadjuvant Furmonertinib Plus Bevacizumab or Furmonertinib Monotherapy for Resectable and Potentially Resectable Stage III-IVA EGFR Mutation-Positive Lung Adenocarcinoma NCT05503667Phase 21 site๐Ÿ“ Shanghai Shanghai Pulmonary Hospital, Shanghai, China ยท Tests: Furmonertinib, Bevacizumab SBRT Followed by Neoadjuvant Chemoimmunotherapy of Sindilizumab Plus Docetaxel and Cisplatin for Locoregionally Advanced Squamous Carcinoma of Oral Cavity and Oropharynx NCT06219980Phase 21 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: SBRT+chemoimmunotherapy Neoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical Cancer NCT06289062Phase 22 sites๐Ÿ“ Guangzhou๐Ÿ“ Wuhan Tongji Hospital ยท Tests: Camrelizumab, Cisplatin, Nab paclitaxel, biopsy Radiological Prediction of Response to Neoadjuvant Chemoimmunotherapy for Triple-negative Breast Cancer NCT06879704NA1 site๐Ÿ“ Rouen Centre Henri Becquerel ยท Tests: Imaging assessment Neoadjuvant Anti-PD-1 Plus Chemotherapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma NCT05740995n/a1 site๐Ÿ“ Shanghai Shanghai Zhongshan Hospital ยท Tests: neoadjuvant anti-PD-1 plus chemotherapy Imaging-based PRediction of Eligibility for ChemoImmunotherapy in reSEctable NSCLC, iPRECISE NCT07559123n/a1 site๐Ÿ“ Seoul Samsung Medical Center ยท Tests: High-resolution deep learning-based CT reconstruction Prospective Cohort Study on Oral Microbiome Changes in Patients With Locally Advanced Oral Squamous Cell Carcinoma Following Neoadjuvant Chemoimmunotherapy NCT07111455n/a1 site๐Ÿ“ Guangzhou Zhujiang Hospital Multimodal Deep Learning for Predicting Treatment Response to Neoadjuvant Chemoimmunotherapy in Esophageal Cancer NCT07063901n/a1 site๐Ÿ“ Changsha Central South University NeoCARD: Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Triple-Negative Breast Cancer Patients NCT06845319Phase 21 site๐Ÿ“ Charleston Medical University of South Carolina ยท Tests: Carboplatin, Paclitaxel, Pembrolizumab A Study Evaluating Neoadjuvant Chemoimmunotherapy With Immunosensitizing Radiation for Borderline Resectable Non-Small Cell Lung Cancer NCT06800339Phase 14 sites๐Ÿ“ Baltimore๐Ÿ“ Baltimore๐Ÿ“ Bel Air University of Maryland, Baltimore ยท Tests: Nivolumab, Chemotherapy, SBRT, Surgical Resection The Value of CEUS in Assessing the Response of Cervical Lymph Nodes After NACI for HNSCC NCT06727162n/a1 site๐Ÿ“ Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University ยท Tests: Contrast-Enhanced Ultrasound Optimizing Neoadjuvant Treatment Regimens for Locally Advanced Esophageal Squamous Cell Carcinoma NCT06907602Phase 2, Phase 31 site๐Ÿ“ Beijing Peking Union Medical College Hospital ยท Tests: Chemotherapy, Immunotherapy (Pembrolizumab), radiotherapy Node-Sparing Short-Course Radiotherapy (25 Gy/5 Fractions) Combined With Chemoimmunotherapy as Neoadjuvant Treatment for Locally Advanced Esophageal Squamous Cell Carcinoma๏ผšA Prospective Single-Arm, Phase II Study NCT07808853Phase 21 site๐Ÿ“ Guanzhou Sixth Affiliated Hospital, Sun Yat-sen University ยท Tests: Neoadjuvant SCRT + Camrelizumab + Nab-Paclitaxel/Carboplatin Tumor Margin Skin Tattooing Before Neo-adjuvant Chemotherapy in Patients With Breast Cancer NCT07478900NA1 site๐Ÿ“ Bhubaneswar All India Institute of Medical Sciences, Bhubaneswar ยท Tests: Skin Tattooing of Tumor Margins Prior to Neoadjuvant Chemotherapy in Breast Cancer Patients: Prospective cohort study
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy